Skip to main content

Table 1 Clinical characteristic of LUSC (n = 501) from TCGA database

From: A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma

Clinical characteristic N %
Age
  ≤ 65 190 37.9
  > 65 302 60.3
 NA 9 1.8
Sex
 Female 130 25.9
 Male 371 74.1
AJCC stage
 I 3 0.6
 IA 90 18.0
 IB 151 30.1
 II 3 0.6
 IIA 65 13.0
 IIB 94 18.8
 III 3 0.6
 IIIA 63 12.6
 IIIB 18 3.6
 IV 7 1.4
 NA 4 0.8
T
 T1 114 22.7
 T2 293 58.5
 T3 71 14.2
 T4 23 4.6
N
 N0 319 63.7
 N1 131 26.1
 N2 40 8.0
 N3 5 1.0
 NA 6 1.2
M
 M0 411 82.0
 M1 7 1.4
 NA 83 16.6
Survival time
 Reported 495 98.8
 NA 6 1.2
Survival status
 Alive 286 57.1
 Dead 215 42.9
  1. Abbreviations: LUSC Lung squamous cell carcinoma, TCGA The cancer genome atlas, NA Not available, AJCC American joint committee on cancer